Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase

Seung Yoon Park, Wan Lee, Jaetae Lee, In-San Kim

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The current study was designed to evaluate the anti-tumor effects of MDR1 shRNA in combination with herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene therapy system. Introduction of an MDR1-targeted small hairpin RNA (shMDR) markedly enhanced the intracellular accumulation of and increased sensitivity to drugs transported by P-glycoprotein. Functional TK-eGFP fusion protein expression was confirmed by Western blot analysis and ganciclovir uptake assay. Compared with GCV or doxorubicin alone, the combination of anti-cancer drug chemotherapy with GCV administration displays additive cytotoxicity in shMDR1-TK-eGFP expressing cells. These results for the first time suggest the potential of combination gene therapy using suicide gene therapy and RNAi-based gene therapy in vitro.

Original languageEnglish
Pages (from-to)205-214
Number of pages10
JournalCancer letters
Volume261
Issue number2
DOIs
Publication statusPublished - 2008 Mar 18
Externally publishedYes

Fingerprint

MDR Genes
Thymidine Kinase
Simplexvirus
Genetic Therapy
Small Interfering RNA
Ganciclovir
Suicide
P-Glycoprotein
Pharmaceutical Preparations
Doxorubicin
Neoplasms
Western Blotting
Drug Therapy
Proteins

Keywords

  • Combination gene therapy
  • HSV-tk
  • MDR1
  • shRNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase. / Park, Seung Yoon; Lee, Wan; Lee, Jaetae; Kim, In-San.

In: Cancer letters, Vol. 261, No. 2, 18.03.2008, p. 205-214.

Research output: Contribution to journalArticle

@article{195193500c204d59b5b8bd569a1c8da7,
title = "Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase",
abstract = "The current study was designed to evaluate the anti-tumor effects of MDR1 shRNA in combination with herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene therapy system. Introduction of an MDR1-targeted small hairpin RNA (shMDR) markedly enhanced the intracellular accumulation of and increased sensitivity to drugs transported by P-glycoprotein. Functional TK-eGFP fusion protein expression was confirmed by Western blot analysis and ganciclovir uptake assay. Compared with GCV or doxorubicin alone, the combination of anti-cancer drug chemotherapy with GCV administration displays additive cytotoxicity in shMDR1-TK-eGFP expressing cells. These results for the first time suggest the potential of combination gene therapy using suicide gene therapy and RNAi-based gene therapy in vitro.",
keywords = "Combination gene therapy, HSV-tk, MDR1, shRNA",
author = "Park, {Seung Yoon} and Wan Lee and Jaetae Lee and In-San Kim",
year = "2008",
month = "3",
day = "18",
doi = "10.1016/j.canlet.2007.11.011",
language = "English",
volume = "261",
pages = "205--214",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase

AU - Park, Seung Yoon

AU - Lee, Wan

AU - Lee, Jaetae

AU - Kim, In-San

PY - 2008/3/18

Y1 - 2008/3/18

N2 - The current study was designed to evaluate the anti-tumor effects of MDR1 shRNA in combination with herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene therapy system. Introduction of an MDR1-targeted small hairpin RNA (shMDR) markedly enhanced the intracellular accumulation of and increased sensitivity to drugs transported by P-glycoprotein. Functional TK-eGFP fusion protein expression was confirmed by Western blot analysis and ganciclovir uptake assay. Compared with GCV or doxorubicin alone, the combination of anti-cancer drug chemotherapy with GCV administration displays additive cytotoxicity in shMDR1-TK-eGFP expressing cells. These results for the first time suggest the potential of combination gene therapy using suicide gene therapy and RNAi-based gene therapy in vitro.

AB - The current study was designed to evaluate the anti-tumor effects of MDR1 shRNA in combination with herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene therapy system. Introduction of an MDR1-targeted small hairpin RNA (shMDR) markedly enhanced the intracellular accumulation of and increased sensitivity to drugs transported by P-glycoprotein. Functional TK-eGFP fusion protein expression was confirmed by Western blot analysis and ganciclovir uptake assay. Compared with GCV or doxorubicin alone, the combination of anti-cancer drug chemotherapy with GCV administration displays additive cytotoxicity in shMDR1-TK-eGFP expressing cells. These results for the first time suggest the potential of combination gene therapy using suicide gene therapy and RNAi-based gene therapy in vitro.

KW - Combination gene therapy

KW - HSV-tk

KW - MDR1

KW - shRNA

UR - http://www.scopus.com/inward/record.url?scp=39149143350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149143350&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2007.11.011

DO - 10.1016/j.canlet.2007.11.011

M3 - Article

C2 - 18096314

AN - SCOPUS:39149143350

VL - 261

SP - 205

EP - 214

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -